Mandate

Vinge advises Gotlandsbolaget in connection with off-take agreement regarding biogas

February 17, 2025 Commercial Agreements M&A

Vinge has advised Rederiaktiebolaget Gotland (Gotlandsbolaget) in connection with the entry into of a strategic off-take agreement, which secures the long-term supply of biogas for the Gotland ferry service traffic.

Gotlandsbolaget aims to offer climate-neutral crossings between Gotland and the mainland by 2045. In order to do this, large volumes of fossil-free fuels are required. Vinge has advised Gotlandsbolaget in an investment in the construction of a biogas plant outside Eskilstuna for the production of high-quality biogas and the negotiation and execution of a 10-year off-take agreement regarding the purchase and delivery of the biogas produced. As a result of this transaction, Gotlandsbolaget has taken important steps towards achieving its goal of climate-neutral crossings between Gotland and the mainland. The plant is expected to be operational in 2026.

 

Vinge’s team consisted primarily of Malin Ohlin and Mario Saad.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025